Trial Profile
The Effect of Dexmedetomidine on the Emergence Agitation in Nasal Surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Apr 2013
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Agitation
- Focus Therapeutic Use
- 07 Aug 2012 Actual end date (Aug 2012) added as reported by ClinicalTrials.gov.
- 01 Aug 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jan 2012 New trial record